Learn more

REPUBLIC OF KOREA(ANIMAL AND PLANT QUARANTINE AGENCY)

Overview
  • Total Patents
    29
  • GoodIP Patent Rank
    55,413
About

REPUBLIC OF KOREA(ANIMAL AND PLANT QUARANTINE AGENCY) has a total of 29 patent applications. Its first patent ever was published in 2015. It filed its patents most often in Republic of Korea. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION, MEDICAL DIAGNOSTIC LAB LLC and CHONGQING GAOSHENG BIOLOGICAL MEDICINE CO LTD.

Patent filings in countries

World map showing REPUBLIC OF KOREA(ANIMAL AND PLANT QUARANTINE AGENCY)s patent filings in countries
# Country Total Patents
#1 Republic of Korea 29

Patent filings per year

Chart showing REPUBLIC OF KOREA(ANIMAL AND PLANT QUARANTINE AGENCY)s patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Cho In Soo 10
#2 Song Jae Young 8
#3 Cha Sang Ho 6
#4 Ouh In Ohk 6
#5 Yu Ji Eun 6
#6 Jeon Eun Sung 5
#7 Jo Hyun Ye 5
#8 Lee Sang Oh 5
#9 Kim Ha Hyun 5
#10 Yang Dong Kun 5

Latest patents

Publication Filing date Title
KR20200085238A Recombinant Influenza A virus and Vaccine Composition for H5 Serotype Influenza A virus belonging to clade 2.3.4.4B comprising the same
KR20200085136A Recombinant Influenza A virus and Vaccine Composition for H5 Serotype Influenza A virus belonging to clade 2.3.4.4B comprising the same
KR20200085396A H5N6 strain Recombinant Influenza A virus and Vaccine Composition for H5 Serotype Influenza A virus belonging to clade 2.3.4.4D comprising the same
KR20200085135A H5N8 strain Recombinant Influenza A virus and Vaccine Composition for H5 Serotype Influenza A virus belonging to clade 2.3.4.4A comprising the same
KR20200082118A Recombinant vector, transformed E.coli, vaccine composition comprising recombinant protein derived from heavy-chain C-terminal domain of Clostridium botulinum type D/C
KR101746401B1 Composition for the prevention or treatment of bovine spongiform encephalopathy containing (E)-3,4-dihydroxystyryl 2,3,4-trihydroxybutanoate
KR101777256B1 Method for evaluating cytotoxic ability of T cell for pathogen infected-cells
KR101777252B1 Method for evaluating suppression ability of T cell for PRRSV infected-cells
KR20170141493A Novel PRRSV European type E38 strain having high-potency
KR20170135410A PNA probe for Differentiating Recombinant CSFV Vaccinated Swine and Wild Type CSFV Infected Swine, and Differeanting Method Using Thereof
KR20170117714A Novel strains of avian pathogenic Escherichia coli
KR20170101655A A diagnostic method to measure antibody against Japanese encephalitis virus using an enzyme linked immunosorvent assay (ELISA)
KR20170079550A The diagnostic method for the detection of antibody against Getah virus in horse
KR20170079564A Primer sets for differentiation between vaccine and wild strain of Aujeszky's disease virus and method for differentiation thereof using the same
KR20170059090A Specific primer set for diagnosing Curtobacterium flaccumfaciens pv. flaccumfaciens, quarantine plant pathogen and uses thereof
KR20170059088A Specific primer set for diagnosing Clavibacter michiganensis subsp. nebraskensis, quarantine plant pathogen and uses thereof
KR20170059087A Specific primer set for detecting Acidovorax cattleyae, quarantine plant pathogen and uses thereof
KR20170053190A Rapid Kit for Diagnosing Porcine Respiratory Reproductive Syndrome Virus Antigen
KR20170046836A Rapid Kit for Diagnosing the specific antibodies against Porcine Respiratory Reproductive Syndrome Virus
KR20170041956A Rapid Kit for Diagnosing the specific antibodies against European type Porcine Respiratory Reproductive Syndrome Virus